Exaggerated glucagon-like peptide-1 and blunted glucose-dependent insulinotropic peptide secretion are associated with Roux-en-Y gastric bypass but not adjustable gastric banding
Top Cited Papers
- 31 December 2007
- journal article
- Published by Elsevier BV in Surgery for Obesity and Related Diseases
- Vol. 3 (6), 597-601
- https://doi.org/10.1016/j.soard.2007.08.004
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Incretins and other peptides in the treatment of diabetesDiabetic Medicine, 2007
- Hyperinsulinemic Hypoglycemia After Gastric Bypass Surgery Is Not Accompanied by Islet Hyperplasia or Increased β-Cell TurnoverDiabetes Care, 2006
- Mechanisms of Recovery From Type 2 Diabetes After Malabsorptive Bariatric SurgeryDiabetes, 2006
- Gut Hormone Profiles Following Bariatric Surgery Favor an Anorectic State, Facilitate Weight Loss, and Improve Metabolic ParametersAnnals of Surgery, 2006
- Gastrointestinal surgery and gut hormonesCurrent Opinion in Endocrinology, Diabetes and Obesity, 2005
- Weight loss through ileal transposition is accompanied by increased ileal hormone secretion and synthesis in ratsAmerican Journal of Physiology-Endocrinology and Metabolism, 2005
- GIP as a Potential Therapeutic Agent?Hormone and Metabolic Research, 2004
- Tissue and plasma concentrations of amidated and glycine-extended glucagon-like peptide I in humansDiabetes, 1994
- Emptying of the gastric substitute, glucagon-like peptide-1 (GLP-1), and reactive hypoglycemia after total gastrectomyDigestive Diseases and Sciences, 1991
- Plasma Enteroglucagon after Jejunoileal Bypass with 3:1 or 1:3 Jejunoileal RatioScandinavian Journal of Gastroenterology, 1979